Browser storage is unavailable. Keep this page open and export your collection before leaving.
Reverie Labs is engineering next-generation, brain-penetrant cancer therapies.
General Partner @ YC Formerly CTO and Co-Founder at Reverie Labs. We started by building software for pharma companies to make better decisions with cutting-edge AI. We ended as a pharma company developing our own pipeline of assets using our ML tools. We sold Reverie to Ginkgo in February 2024. Previously AB/SM at Harvard in CS. I'm an ML research guy turned infra, full stack, data science, and everything in between.
Founded 2017 · Source
Source-based assessment · automated evidence rules
The source reports an inactive or acquired company; current product identity needs review.
Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.
Anthrogen is engineering post-modality biology. Today's modalities reflect historical contingencies in biological progress, not fundamental categories. We develop the AI systems that design modular biological machines and the…
Founders · Product
Same product type · Infrastructure
Anto is building a foundation model for microbial communities, making the gut microbiome computable for the first time. We predict drug toxicity and efficacy across diverse populations and fix drugs so they work for everyone — solving…
Founders · Product
Same product type · Infrastructure
BioStack is building the data engine for healthcare and drug discovery AI. The bottleneck is not models. It is access to high-quality biological data. Clinical and experimental data is fragmented, unstructured, and locked inside…
Founders · Product
Same product type · Infrastructure
Transform scattered lab data into structured insights. Labric automatically captures instrument data, enables AI-powered analysis, and saves research teams hundreds of hours.
Founders · Product · How it works
Same product type · Infrastructure
What if we made as many cancer drugs next year as we have in the last decade?
Founders · Product
Same product type · Infrastructure
Spatial proteomics from H&E and multimodal patient data imputation. Lattice predicts spatially resolved protein-marker maps from routine H&E slides as virtual multiplex immunofluorescence (mIF) channels, transforming incomplete patient…
Founders · Product · How it works
Same product type · Infrastructure
